Edition:
United Kingdom

Apellis Pharmaceuticals Inc (APLS.OQ)

APLS.OQ on NASDAQ Stock Exchange Global Select Market

12.88USD
12 Dec 2017
Change (% chg)

$-1.64 (-11.29%)
Prev Close
$14.52
Open
$14.49
Day's High
$14.49
Day's Low
$12.81
Volume
35,075
Avg. Vol
--
52-wk High
$15.40
52-wk Low
$12.55

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Gerald Chan

66 2016 Chairman of the Board

Cedric Francois

44 2016 President, Chief Executive Officer, Co-Founder, Director

Pascal Deschatelets

45 2016 Co-Founder, Chief Operating Officer

Alec Machiels

43 2016 Co-Founder, Director

Daniel Geffken

2015 Interim Chief Financial Officer